Clinical Trial Update: Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145) [Phase 2]

View source ↗

Summary

Phase 2 trial of preladenant for neuroleptic-induced akathisia was terminated with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Akathisia
• Movement Disorders

Drugs mentioned

• preladenant (preladenant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Akathisia, Drug-Induced, Antipsychotic Agents | Phase 2 | Status: TERMINATED | Results posted: 2017-05-24